Before the Bell Scans: Becton, Dickinson and Co., MAKO Surgical, Repros Therapeutics, and Align Technology
LONDON, July 16, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
On Monday, July 15, 2013, shares in healthcare companies ended on a mixed note even as the broader market edged higher. The major movers in the sector included Becton, Dickinson and Co. (NYSE: BDX), MAKO Surgical Corp. (NASDAQ: MAKO), Repros Therapeutics Inc. (NASDAQ: RPRX), and Align Technology Inc. (NASDAQ: ALGN). All these companies are tracked by AAAResearchReports.com. Free technical research on BDX, MAKO, RPRX, and ALGN can be downloaded upon sign up at:
http://www.aaaresearchreports.com/register/
Shares in Becton, Dickinson and Co. ended slightly higher on Monday, tracking gains in the broader market. The company's shares finished the day 0.16% higher at $102.17 after oscillating between $101.53 and $102.32. A total of 401,411 shares were traded which is less than its daily average volume of 922,005. Becton, Dickinson and Co.'s shares have gained 3.10% in the last three trading sessions, and 7.73% in the last three months. Moreover, the stock is currently trading near its 52-week high of $102.72. Sign up today to read free research report on BDX at:
http://www.AAAResearchReports.com/BDX071613.pdf
MAKO Surgical Corp.'s stock rose sharply on Monday, extending its gains from previous trading sessions. The company's shares closed the session 1.44% higher at $12.64 after oscillating between $12.22 and $13.09. A total of 1.40 million shares were traded which is more than its daily average volume of 686,276. MAKO Surgical's shares have gained 8.87% in the last three trading sessions, and 19.36% in the last three months. Register to download free technical analysis on MAKO at:
http://www.AAAResearchReports.com/MAKO071613.pdf
Shares in Repros Therapeutics Inc. moved lower on Monday, reversing some of their gains from previous trading sessions. The company's shares fluctuated between $19.67 and $20.99 before finishing the day 1.67% lower at $20.06. A total of 272,139 shares were traded which is below the daily average volume of 478,547. Repros Therapeutics' shares have gained 2.03% in the last three trading sessions, and 22.99% in the last three months, thus outperforming the S&P 500. Furthermore, the stock is currently trading near its 52-week high of $21.25. A free report on RPRX can be accessed by registering at:
http://www.AAAResearchReports.com/RPRX071613.pdf
Align Technology Inc.'s stock edged lower on Monday even as the broader market posted gains. The company's shares fluctuated between $38.69 and $39.30 before ending the day 1.28% lower at $38.70. A total of 535,259 shares were traded which is below the daily average volume of 620,068. Despite Monday's pullback, Align Technology's shares are currently trading near their 52-week high of $39.82. In the last three months, the stock has gained 24.04%, thus outperforming the S&P 500 which has gained 8.38% in the same period. Register with AAA Research Reports and download the research on ALGN for free at:
http://www.AAAResearchReports.com/ALGN071613.pdf
----
EDITOR NOTES:
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected].
- For any urgent concerns or inquiries, please contact us at [email protected].
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to [email protected] for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
SOURCE AAA Research Reports
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article